Levofloxacin

Levofloxacin, the active ingredient in Levofloxacin, is a fluoroquinolone presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in adult patients, including pneumonia and complicated urinary or intra‑abdominal infections.

GNH USA supplies Levofloxacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacin is a broad‑spectrum antibacterial indicated for several serious infections.

Community‑acquired pneumonia: achieves bacterial eradication and clinical cure in adult patients. Hospital‑acquired pneumonia: provides effective treatment against resistant Gram‑negative pathogens. Complicated urinary tract infections: clears infection and prevents recurrence. Complicated intra‑abdominal infections: resolves polymicrobial infections after surgical source control. Skin and soft tissue infections: reduces bacterial load and promotes healing.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea or vomiting - Diarrhea - Headache - Dizziness - Rash or pruritus - Elevated liver enzymes

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation and cardiac arrhythmias - Clostridioides difficile‑associated colitis - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Seizures or neurotoxicity - Peripheral neuropathy

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

Assess renal function: adjust therapy in patients with impaired clearance. Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. Avoid in patients with known hypersensitivity to fluoroquinolones. Use caution in individuals with prolonged QT interval or cardiac disease. Review concomitant medications that may prolong QT or affect drug metabolism. Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Antiarrhythmics such as amiodarone: increased risk of QT prolongation. - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Oral contraceptives: potential reduction in contraceptive efficacy. - Theophylline: possible increase in theophylline serum concentrations.